NeuroSense Therapeutics Ltd. Stockholders' Equity Note, Changes in Capital Structure, Subsequent Changes to Number of Common Shares
NeuroSense Therapeutics Ltd. (NRSN) had Stockholders' Equity Note, Changes in Capital Structure, Subsequent Changes to Number of Common Shares of 90.00 million shares as of 2024-06-27, per its 20-F filed 2025-04-07.
Financial Statements › Notes › Equity › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteChangesInCapitalStructureSubsequentChangesToNumberOfCommonShares · last filed 2025-04-07
- 2024-06-27: Stockholders' Equity Note, Changes in Capital Structure, Subsequent Changes to Number of Common Shares 90.00M shares.
| Period end | Stockholders' Equity Note, Changes in Capital Structure, Subsequent Changes to Number of Common Shares |
|---|---|
| 2024-06-27 | 90.00M shares 20-F · filed 2025-04-07 |